chloroquine has been researched along with Neglected Diseases in 3 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Neglected Diseases: Diseases that are underfunded and have low name recognition but are major burdens in less developed countries. The World Health Organization has designated six tropical infectious diseases as being neglected in industrialized countries that are endemic in many developing countries (HELMINTHIASIS; LEPROSY; LYMPHATIC FILARIASIS; ONCHOCERCIASIS; SCHISTOSOMIASIS; and TRACHOMA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sykes, ML | 1 |
| Avery, VM | 1 |
| Previti, S | 1 |
| Ettari, R | 1 |
| Cosconati, S | 1 |
| Amendola, G | 1 |
| Chouchene, K | 1 |
| Wagner, A | 1 |
| Hellmich, UA | 1 |
| Ulrich, K | 1 |
| Krauth-Siegel, RL | 1 |
| Wich, PR | 1 |
| Schmid, I | 1 |
| Schirmeister, T | 1 |
| Gut, J | 1 |
| Rosenthal, PJ | 1 |
| Grasso, S | 1 |
| Zappalà, M | 1 |
| Waheed, AA | 1 |
| Ghanchi, NK | 1 |
| Rehman, KA | 1 |
| Raza, A | 1 |
| Mahmood, SF | 1 |
| Beg, MA | 1 |
1 review available for chloroquine and Neglected Diseases
| Article | Year |
|---|---|
Approaches to protozoan drug discovery: phenotypic screening.
Topics: Drug Discovery; Humans; Molecular Structure; Neglected Diseases; Phenotype; Plasmodium falciparum; P | 2013 |
2 other studies available for chloroquine and Neglected Diseases
| Article | Year |
|---|---|
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).
Topics: Antimalarials; Carbamates; Cathepsin L; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dip | 2017 |
Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat.
Topics: Adult; Antimalarials; Chloroquine; Communicable Diseases, Emerging; Drug Resistance; Female; Humans; | 2015 |